May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Effects of muscarinic toxins MT1 and MT7, from green mamba venom, on m1 muscarinic receptor expressed in mouse and human scleral fibroblasts
Author Affiliations & Notes
  • S. Weon
    Singapore Eye Research Institute, Singapore, Singapore
  • J. Chew
    Singapore Eye Research Institute, Singapore, Singapore
  • A. Barathi
    Singapore Eye Research Institute, Singapore, Singapore
    Dept.Ophthalmology, National University of Singapore, Singapore, Singapore
  • R.W. Beuerman
    Singapore Eye Research Institute, Singapore, Singapore
    Dept.Ophthalmology, National University of Singapore, Singapore, Singapore
  • Footnotes
    Commercial Relationships  S. Weon, None; J. Chew, None; A. Barathi, None; R.W. Beuerman, None.
  • Footnotes
    Support  NMRC IBG
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 1240. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. Weon, J. Chew, A. Barathi, R.W. Beuerman; Effects of muscarinic toxins MT1 and MT7, from green mamba venom, on m1 muscarinic receptor expressed in mouse and human scleral fibroblasts . Invest. Ophthalmol. Vis. Sci. 2004;45(13):1240.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:Several small proteins called muscarinic toxins (MTs) have been isolated from venom of the green mamba. MTs recognize muscarinic receptors and MT7 is the most selective ligand for m1 muscarinic receptor. We have investigated the effect of MTs, compared them with conventional antagonists and confirmed the presence of the m1 receptor on mouse and human scleral fibroblasts (SFs). Methods:Experimental myopia was induced in 30 mice by 8 weeks of lid–suture on right eyes (OD) and left eyes (OS) were used controls. Scleras of mice and scleral rims from donor human corneas were cultured and SFs used at passage 2–4. Proliferation studies using BrdU were carried out with atropine and pirenzepine at 0.0, 0.1, 1, 10, 100 µ M, and MT7 at 0.0, 0.5, 1, 2, 4 µ M. Agonists MT1 and carbachol were used at 0.0, 0.5, 1, 2, 4 µ M, and 0.0, 0.1, 1, 10, 100 µ M respectively. Presence of the m1 receptor was confirmed by immunostaining, western blots, (m1 antibody from Biogenesis) and RT–PCR for the m1 receptor. Results:The m1 muscarinic receptor was detected in mouse and human SFs by immunostaining and western blots. RT–PCR confirmed the presence of the message for the m1 receptor in mouse and human SFs. Pirenzepine and MT7, selective m1 muscarinic receptor antagonists inhibited proliferation of SFs in a dose dependent manner (p<0.05, n=4, ANOVA). Atropine, a general muscarinic receptor antagonist, also inhibited proliferation of SFs in a dose dependent manner (p<0.05, n=4, ANOVA). At a concentration of 1µ M, MT7 was more inhibitory than either atropine or pirenzepine (0.73, 0.38, 0.24). In contrast, MT1, a reversible m1 muscarinic receptor agonist, and carbachol increased cell proliferation in a dose dependent manner (p<0.05, n=4, ANOVA); however, MT1 was more stimulatory than carbachol at 1µ M (0.24 to 0.13). Conclusions:Our results show that the mAChRs m1 subtype exists in mouse and human SFs, and that m1 receptor participates in the control of cell proliferation in mouse and human SFs.

Keywords: sclera • myopia 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×